Full name
FARMACJA WARSZAWSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.17.Z - Activity of agents involved in wholesale trade of food, beverages, and tobacco products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
75.00.Z - Veterinary activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | 0,4 | 1,3 | 233 |
EBITDA | 1,1 | 0,6 | 1,6 | 179 |
Short time liabilities | 5,6 | 10 | 9,9 | -1,2 |
Equity capital | 4 | 4,3 | 5,5 | 27,8 |
Operating profit (EBIT) | 0,9 | 0,4 | 1,5 | 267,7 |
Assets | 9,6 | 14,3 | 15,4 | 7,5 |
Net profit (loss) | 0,7 | 0,3 | 1,2 | 291,3 |
Cash | 0,3 | 0,4 | 0,1 | -70,4 |
Liabilities and provisions for liabilities | 5,6 | 10 | 9,9 | -1,2 |
Net income from sale | 40,1 | 45,6 | 60,9 | 33,4 |
Working assets | 9,1 | 13,9 | 15 | 8,3 |
Depreciation | 0,2 | 0,2 | 0,1 | -44,3 |
% | % | % | p.p. | |
Profitability of capital | 18,2 | 7,1 | 21,8 | 14,7 |
Equity capital to total assets | 41,4 | 29,9 | 35,5 | 5,6 |
Gross profit margin | 2,3 | 0,9 | 2,2 | 1,3 |
EBITDA Margin | 2,9 | 1,3 | 2,7 | 1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 80 | 59 | -21 |
Current financial liquidity indicator | 1.6262649297714233 | 1.3858007192611694 | 1.5186781883239746 | 0,1 |
Net dept to EBITDA | -0.2232937216758728 | 2.4504740238189697 | 1.3636102676391602 | -1,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane